Ab Initio Biotherapeutics Overview
- Founded
- 2015
- Status
- Acquired/Merged
- Latest Deal Type
- M&A
- Latest Deal Amount
- $12M
Ab Initio Biotherapeutics General Information
Description
Developer of protein engineering platform designed for the discovery of therapeutic antibodies against difficult-to-access cellular targets. The company's platform allows for targeting multi-transmembrane and facilitates antibody generation relevant to a wide array of therapeutic indications including neurological, cardiovascular, endocrine and gastrointestinal disorders, enabling doctors to optimize the solubility and stability of drugs.
Contact Information
Website
www.aibio.com
Ownership Status
Acquired/Merged
Financing Status
Formerly Accelerator/Incubator backed
Primary Office
- 280 Utah Avenue
- South San Francisco, CA 94080
- United States
Ab Initio Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 23-Jul-2019 | $12M | 000 | 0000 | Completed | Generating Revenue |
| 3. Corporate | 13-Dec-2016 | 000 | Completed | Startup | ||
| 2. Angel (individual) | $2M | $2M | Completed | Startup | ||
| 1. Accelerator/Incubator | 03-Mar-2015 | Completed | Startup |
Ab Initio Biotherapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of protein engineering platform designed for the discovery of therapeutic antibodies against difficult-to-acce
Biotechnology
South San Francisco, CA
000
000
0000-00-00
000000&0
000
0000000
im ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequa
0000 000000000
Maastricht, Netherlands
00
As of 0000
000.00
0000000000
000.00
000000 0
fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia des
0000000000000
South San Francisco, CA
000
As of 0000
00000
00000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialAb Initio Biotherapeutics Competitors (24)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Cristal Therapeutics | Venture Capital-Backed | Maastricht, Netherlands | 00 | 000.00 | 0000000000 | 000.00 |
| 000000 00000000000 | Formerly VC-backed | South San Francisco, CA | 000 | 00000 | 00000000 | 00000 |
| 000000000 | Formerly VC-backed | Tucson, AZ | 00 | 000.00 | 000000&0 | 000.00 |
| 00000000 | Formerly VC-backed | Paris, France | 00 | 000.00 | 000000000 | 000.00 |
| 0000000 0000000000 | Formerly VC-backed | Brisbane, CA | 000 | 0000 | 00000000 | 0000 |
Ab Initio Biotherapeutics Executive Team (6)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Robert Booth Ph.D | Co-Founder & Executive Chairman |
Ab Initio Biotherapeutics Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Robert Booth Ph.D | Self | Co-Founder & Executive Chairman | 000 0000 |
Ab Initio Biotherapeutics Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Pfizer | Corporation | Minority | 000 0000 | 000000 0 | |
| Polaris Partners | Venture Capital | Minority | 000 0000 | 000000 0 |